News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ambry Genetics Initiates Fluidigm Corporation-Based Genomic Research Services for Gene Expression, SNP Genotyping and Sample Prep for Targeted Sequencing



4/12/2012 10:17:56 AM

ALISO VIEJO, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a global leader in clinical diagnostics and genomic services, announced today the launch of Fluidigm (NASDAQ:FLDM) BioMark™ HD and Access Array™ System-based genomic research services. These services provide gene expression, SNP genotyping, and sample preparation for targeted sequencing using next-generation sequencers, focused on the genomics research market.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES